Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000672932 | SCV000798088 | likely pathogenic | DE SANCTIS-CACCHIONE SYNDROME; Cerebrooculofacioskeletal syndrome 1; Cockayne syndrome type 2 | 2018-02-22 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001172036 | SCV001334965 | likely pathogenic | not provided | 2020-02-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001172036 | SCV001592893 | pathogenic | not provided | 2021-07-20 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with ERCC6-related conditions. For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 556870). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Pro70Alafs*17) in the ERCC6 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ERCC6 are known to be pathogenic (PMID: 18628313, 29572252). |